… 16 or 18 at baseline, with the HPV 16/18 vaccine. This period is the longest reported for any
HPV vaccine so far. No breakthrough cases of HPV 16/18 persistent infection or associated …

… global strategy may be the accelerator needed to complete the introduction worldwide and
improve HPV vaccine coverage globally… likely to provide access to vaccination. Fortunately, …

… between the global north and south persist. We illustrate worldwide HPV vaccine implementation
and … By rapidly expanding access to HPV vaccination to girls everywhere, vaccine-type …

… infection for healthy young girls 29 but the quality of existing evidence is not robust enough
for a global recommendation. Randomized controlled trials, observational studies, and …

… a revolution in global HIV/AIDS treatment, with three million people gaining access mostly to
… Whether we are likely to see a similar pattern develop in HPV vaccine access may depend …

… 2.2 | Expanding access Access to HPV vaccination in LLMICs has been facilitated by financial
… global scale- up of HPV vaccinations: more than 100 countries now have experience with …

… 50 % of middle-income countries that introduced were in the Americas region, where the
PAHO revolving fund has secured access to a lower price for HPV vaccines for its members. …

… The delivery approach is among the factors which impact the access to HPV vaccination,
with the most equitable one possibly being a school-based program [84], [85]. This approach …

… Middle-income countries without access to Gavi or PAHO prices (referred to as “the missing
… with funding provided by Gavi, the Vaccine Alliance and collaborates with global partners in …

… The aim of this study is to evaluate the status of HPV vaccination coverage from nationally
reported indicators and to estimate global coverage in a single year cohort of vaccine-eligible …